摘要
目的分析血液肿瘤患者血流感染(bloodstream infection,BSI)病原菌分布和耐药特点,探讨发生BSI的危险因素。方法选取2013年1月至2018年6月,江苏大学附属昆山医院血液肿瘤住院患者344例,抽取患者8~10ml外周静脉血进行病原菌培养,应用多因素logistic回归分析方法分析血培养阳性的危险因素。结果107例发生BSI的血液肿瘤患者血液样本共分离出112株病原菌,其中革兰阴性菌61株(54.47%),革兰阳性菌36株(32.14%),真菌15株(13.39%)。多因素logistic回归分析显示,年龄≥60岁[OR(95%CI)=3.63(1.10~10.02)];有侵入性操作[OR(95%CI)=2.12(1.12~11.14)];粒细胞缺乏≥7d[OR(95%CI)=2.45(1.14~9.85)]和有其他部位感染[OR(95%CI)=1.75(1.21~12.24)]是血液肿瘤患者发生BSI的危险因素。结论血液肿瘤患者BSI病原菌主要以革兰阴性菌为主,病原菌耐药情况不容忽视。应从年龄、侵入性操作、粒细胞缺乏以及其他部位感染等方面来预防血液肿瘤患者发生BSI。
Objective To analyze the distribution and drug-resistant features of pathogens causing bloodstream infections(BSI)in patients with hematological malignancies and explore the risk factors for BSI.Methods A total of 344patients with hematological malignancies in Kunshan Hospital Affiliated to Jiangsu Umiversity were enrolled in the study from January 2013to June 2018,and 8~10ml blood specimens were collected and cultured.Multivariate logistic regression method was used for risk factors analysis.Results A total of 112 strains of pathogens were isolated,including 61strains of gram-negative bacteria(54.47%),36strains of gram-positive bacteria(32.14%)and 15strains of fungus(13.39%)in 107patients with hematological malignancies and BSI.Logistic analysis showed that patients aged 60and older(OR=3.63,95%CI:1.10~10.02),with invasive operation(OR=2.12,95%CI:1.12~11.14),having agranulocytosis for 7days and longer(OR=2.45,95%CI:1.14~9.85)and with other infections(OR=1.75,95%CI:1.21~12.24)were more likely to have BSI.Conclusions The gram-negative bacteria are the predominant pathogens causing BSI in patients with hematological malignancies.Comprehensive interventions should be adopted based on patient′s age,invasive procedures,neutropenia,and other infections.
作者
傅爱林
刘成印
沈刚
沈文香
FU Ai-lin;LIU Cheng-yin;SHEN Gang;SHEN Wen-xiang(Departrnent of Hematology Neoplasms,Kunshan Hospital Affiliated to Jiangsu University,Kunshan,Jiangsu 215300,China)
出处
《中国预防医学杂志》
CAS
CSCD
2020年第1期89-93,共5页
Chinese Preventive Medicine
关键词
血液疾病
血流感染
病原菌
抗生素
耐药性
危险因素
Hematological malignancy
Bloodstream infection
Pathogen
Antibiotics
Drug resistance
Risk factor